Learn: Learnhttps://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/page/3/?d=1Learn: LearnenControlled drugs accountable officers and patient safety – a case study: Conference presentation (October 2019)https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/controlled-drugs-accountable-officers-and-patient-safety-%E2%80%93-a-case-study-conference-presentation-october-2019-r845/845Sun, 20 Oct 2019 10:45:00 +0000The NHS Patient Safety strategy has a hole in ithttps://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/the-nhs-patient-safety-strategy-has-a-hole-in-it-r668/668Fri, 27 Sep 2019 09:33:00 +0000Drugs.com: UK medication databasehttps://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/drugscom-uk-medication-database-r648/ The Drugs.com UK database contains drug information on over 1,500 medications distributed within the United Kingdom.

]]>648Wed, 25 Sep 2019 11:41:00 +0000Institute for Safe Medication Practices: Medication safety alert video – Episode 3 (October 2017)https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/institute-for-safe-medication-practices-medication-safety-alert-video-%E2%80%93-episode-3-october-2017-r645/ This issue (episode 3) focuses on:

  • safe administration of concentrated insulin products
  • errors with confusing product labelling
  • educating patients about safe medication practices.
]]>645Wed, 25 Sep 2019 11:13:00 +0000Institute for Safe Medication Practices: Medication safety alert video – Episode 2 (April 2017)https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/institute-for-safe-medication-practices-medication-safety-alert-video-%E2%80%93-episode-2-april-2017-r644/ This issue (episode 2) focuses on:

  • the most common safety issues associated with measuring patient weight
  • steps to eliminate drug concentration confusion
  • understanding Patient Care Analgesia (PCA) by proxy.
]]>644Wed, 25 Sep 2019 11:08:00 +0000Guide to HIQA’s Medication Safety Monitoring Programme against the National Standards for Safer, Better Healthcare in acute healthcare services in 2019https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/guide-to-hiqa%E2%80%99s-medication-safety-monitoring-programme-against-the-national-standards-for-safer-better-healthcare-in-acute-healthcare-services-in-2019-r640/ The purpose of this guide is to provide an understanding of the HIQA 2019 approach to HIQA’s Medication Safety Monitoring Programme against the National Standards for Safer, Better Healthcare to ensure patient safety in relation to medication safety.

This guidance document includes information about the:

  • background to HIQA’s medication safety monitoring programme
  • the next phase of this monitoring programme
  • focus on high-risk medications and high-risk situations
  • format of HIQA’s hospital inspections
  • risk identification and notification processes
  • HIQA inspection reports.
]]>640Fri, 20 Sep 2019 09:45:00 +0000NICE: Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes (March 2015)https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/nice-medicines-optimisation-the-safe-and-effective-use-of-medicines-to-enable-the-best-possible-outcomes-march-2015-r637/ This guideline by NICE, covers safe and effective use of medicines in health and social care for people taking one or more medicines. It aims to ensure that medicines provide the greatest possible benefit to people by encouraging medicines reconciliation, medication review and the use of patient decision aids.

Who is it for?

  • Healthcare professionals.
  • Social care practitioners.
  • Commissioners and providers
  • People taking one or more medicines and their families and carers.
]]>637Fri, 20 Sep 2019 09:13:00 +0000Effectiveness Matters: Reducing harm from polypharmacy in older people (August 2017)https://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/effectiveness-matters-reducing-harm-from-polypharmacy-in-older-people-august-2017-r482/ Key findings:

  • Polypharmacy is common among older people; it can increase the risk of adverse drug reactions and interactions as well as reduce compliance and adherence.
  • Positive (but inconsistent) effects of deprescribing interventions have been observed.
  • Patient and practitioner decisions about stopping medications are influenced by social influences, expected consequences and factors such as consultation length.
  • Practitioners said their own knowledge and skills, plus beliefs about the capabilities of patients could influence their decisions.
  • Patients said their emotions, treatment goals, and willingness to experiment could also influence their decisions.
  • A multifaceted person-centred coordinated care approach, as advocated in NICE clinical guidelines and by the ‘House of Care’ model, should underpin efforts to reduce harm from polypharmacy in older people.
]]>482Thu, 05 Sep 2019 12:46:00 +0000Video - The third WHO Global Patient Safety Challenge: Medication Without Harmhttps://www.pslhub.org/learn/patient-safety-in-health-and-care/medication/medicine-management/video-the-third-who-global-patient-safety-challenge-medication-without-harm-r286/286Fri, 26 Jul 2019 15:07:00 +0000